Related by context. All words. (Click for frequent words.) 78 Vascugel R 70 HDL Selective Delipidation 70 pain palliation 70 Vascugel 69 BrachySil TM 69 functional mitral regurgitation 69 PI3K/Akt pathway inhibitor 68 metastatic neuroendocrine tumors 68 Biolimus A9 68 edifoligide E2F Decoy 68 carotid artery stenting CAS 68 relapsed MM 68 catheter occlusion 68 kidney urologic 68 fosbretabulin 67 HuMax EGFr 67 NAVISTAR R 67 bazedoxifene conjugated estrogens 67 CINQUIL 67 cobiprostone 67 acetonide FA 67 CIMZIA ™ 67 esophagogastric 67 preclinical efficacy 67 Zemplar Capsules 67 Intravitreal 67 zotarolimus 67 reslizumab 67 CYT# potent vascular disrupting 66 GRNCM1 66 liver resection 66 WallFlex Biliary RX 66 acadesine 66 QuadraSphere 66 MAGE A3 ASCI 66 Hepatocellular Carcinoma HCC 66 BrachySil ™ 66 thalidomide Thalomid 66 Platinol ® cisplatin 66 Adaptive Radiation Therapy 66 Xanafide 66 symptomatic paroxysmal AF 66 CBLC# 66 liposomal formulation 66 depsipeptide 66 morphometric vertebral fractures 66 XIENCE V Everolimus Eluting 66 ToGA 66 MYDICAR ® 66 gefitinib Iressa 66 paclitaxel poliglumex 66 eluting stent 66 phase IIb study 66 CIMZIA TM certolizumab pegol 66 wilate ® 66 CRLX# 66 colorectal cancer liver metastases 66 Pertuzumab 66 CTAP# Capsules 65 BEXXAR Therapeutic Regimen 65 Pharmacokinetics PK 65 vaginally administered lidocaine 65 Squalamine 65 cardiac perfusion 65 Carotid Revascularization Endarterectomy vs. 65 riociguat 65 invasive candidiasis 65 multicenter Phase III 65 GORE TAG Device 65 bevacizumab Avastin ® 65 biliary tract cancer 65 vapreotide acetate 65 Adult Stem Cell Therapy 65 Prospective Randomized 65 EOquin TM 65 Alequel 65 renal artery stenting 65 PrevOnco 65 targeted antifolate 65 Ataluren 65 prospective multicenter study 65 Accelerated Partial Breast Irradiation 65 stent DES 65 Factor VIIa 65 glucocorticoid induced osteoporosis 65 Pyridorin 65 acyclovir Lauriad R 65 PEGylated interferon 65 carotid endarterectomy CEA 65 demonstrated antitumor activity 65 mechanical thrombectomy 65 HepDirect prodrug 65 Initiate Clinical Trial 65 STARFlex R 65 Catheter Associated 65 unresectable tumors 65 LHRH receptor positive 65 sirolimus eluting stents 65 everolimus eluting stents 65 polycythemia vera PV 65 multicenter Phase II 65 coronary stenting 65 Nitinol Stent 65 Myocet 65 thromboembolic disease 65 Inhaled nitric oxide 65 Combo Stent 65 colesevelam HCl 64 Bayer HealthCare Onyx Pharmaceuticals 64 Ophena TM 64 antiplatelet compound 64 deferiprone 64 orally inhaled migraine 64 MGuard ™ 64 cisplatin gemcitabine 64 recurrent metastatic 64 Coronary Artery Bypass Graft 64 Bezielle 64 concurrent chemoradiation 64 erlotinib Tarceva ® 64 MGd 64 XIENCE V stent 64 vidofludimus 64 allogeneic cell 64 immunotherapeutic vaccine 64 STRIDE PD 64 Interferon beta 64 Renal Artery 64 phase IIIb 64 Resten NG 64 Diamondback #deg 64 DUROS 64 pharmacokinetic PK study 64 Mitomycin C 64 GOUT 64 sorafenib Nexavar 64 Anti Bacterial Envelope 64 VeriStrat 64 NP2 Enkephalin 64 standard chemotherapy regimen 64 ABSORB trial 64 TASKi3 64 Heart Transplant Recipients 64 Epratuzumab 64 trastuzumab DM1 T DM1 64 histone deacetylase inhibitor 64 Catena ® 64 Randomized Evaluation 64 sunitinib Sutent 64 urethral bulking agent 64 metaglidasen 64 BioMatrix 64 relapsed ALL 64 carotid artery stent 64 somatostatin analog 64 RX ACCULINK 64 Xelox 64 ZACTIMA 64 clevidipine 64 ACTEMRA TM 64 CALGB # [002] 64 recurrent NSCLC 64 ZFP TF 64 metastatic malignant 64 Stabilimax NZ 64 Vascular Wrap TM 64 efficacy tolerability 64 lucinactant 64 Modrenal 64 CryoMaze 64 SinuNase TM 64 anastomotic devices 64 PORxin TM 64 PrevOnco ™ 64 carotid artery stenting 64 Phase 1a clinical 64 Quinamed 64 Sirolimus eluting Coronary Stent 64 Sirolimus eluting 64 coronary stent merged 64 Azedra 64 MTP inhibitor 64 myelodysplastic myeloproliferative diseases 64 RE COVER 63 OHR/AVR# 63 everolimus eluting stent 63 Alfimeprase 63 recurrent glioblastoma multiforme 63 AFRS TM 63 EchoCRT 63 intravascular hemolysis 63 Phase Ib II 63 novel VDA molecule 63 DCVax R 63 malignant ascites 63 sorafenib tablets 63 immunosuppression therapy 63 ATS Simulus R 63 docetaxel Taxotere ® 63 induced macular edema 63 VBLOC TM 63 personalized cellular immunotherapy 63 Val HeFT 63 pulmonary artery banding 63 Tumor Response 63 metastatic colorectal 63 Cx# [002] 63 Phase 1b clinical trials 63 papillary renal cell carcinoma 63 Achieves Primary Endpoint 63 mertansine 63 prospective randomized multicenter 63 alpha1 antitrypsin deficiency 63 novel oral anticoagulant 63 Tarceva TM 63 TM Everolimus Eluting 63 pharmacodynamic PD 63 descending thoracic 63 beta Estradiol 63 Diabetic Foot Ulcer 63 Diabetic Macular Edema DME 63 diagnostic biomarker 63 Fully Covered Stent 63 percutaneous vertebroplasty 63 antithrombotic therapy 63 Afatinib 63 ZOLINZA 63 BRIM2 63 NATRECOR ® 63 Angiographic 63 PRoFESS 63 candidate TNFerade biologic 63 Daclizumab 63 FluCAM arm 63 Glypromate 63 edifoligide 63 targeted radiotherapeutic 63 efaproxiral 63 gastrointestinal stromal tumors GIST 63 ospemifene 63 Deforolimus 63 Rilonacept 63 ExTRACT TIMI 63 Thiarabine 63 microsphere therapy 63 Renal Cell Carcinoma RCC 63 cilengitide 63 CTO recanalization 63 Acute Radiation Syndrome ARS 63 colorectal liver metastases 63 phase IIb clinical 63 teriflunomide 63 ImmuKnow R 63 NV1FGF 63 Thrombolysis 63 afamelanotide 63 DG# compounds targeting 63 thoracoscopic lobectomy 63 Acute Ischemic Stroke 63 Embolic Protection Device 63 demonstrated clinically meaningful 63 unstable angina UA 63 PKC# 63 IMA# 63 Iluvien TM 63 colorectal adenoma 63 elacytarabine 63 Pivotal Trial 63 evaluating tivozanib 63 retinal vein occlusion induced 63 Prolongs Survival 63 HQK 63 Cimzia TM 63 cartilage regeneration 63 PROTEGE 63 Diabetic Neuropathy 63 KL4 Surfactant 63 Fludara ® 63 TNF alpha antagonist 63 Selective Electrochemical Tumor Ablation 63 membranous nephropathy 63 undergoing elective percutaneous 63 Cardio3KG 63 antibody MAb 63 osteoporotic compression fractures 63 venous thromboembolic disease 63 IRX 2 63 SIR Spheres 63 invasive aspergillosis 63 intracavitary 63 cinacalcet 63 galiximab 63 Edge STudy 63 ancrod 63 PDX pralatrexate 63 psoriatic arthritis PsA 63 GEM OS2 63 Surgical resection 63 sirolimus eluting 63 GAMMAGARD 63 GERD migraine headaches 63 ALA PDT 63 vincristine doxorubicin 63 Alequel ™ 63 autologous SCT 63 AV fistula 63 Phase Ib clinical 63 RAS mutations 63 oncolytic virus therapies 63 Doxil ® 63 Traficet EN 63 BRAF inhibitor 63 BR.# 63 Catheter Ablation 63 Patients Treated With 63 EXPAREL ™ 63 allogeneic HSCT 63 Hsp# Inhibitor 63 BEZ# 63 Outpatient Setting 63 UPLYSO 63 keratoplasty 63 refractory ovarian cancer 63 Vascular Wrap 63 drotrecogin alfa activated 63 CHAMPION PCI 63 Fondaparinux 63 recurrent glioma 63 ischemic mitral regurgitation 63 TAKSTA 63 Crofelemer budesonide foam 63 crizotinib PF # 63 TAXUS Express Stent 63 bioresorbable polymer 63 TORISEL 62 transcranial Doppler ultrasound 62 Adhesion Barrier 62 liposomal doxorubicin 62 Isolagen Therapy 62 Acute Decompensated Heart Failure 62 thrombotic complications 62 neratinib 62 tolerability pharmacokinetics 62 neurologic progression 62 Demonstrates Significant 62 Phase #b/#a clinical 62 Curaxin CBLC# 62 MitraClip device 62 EGS# 62 platinum chromium alloy 62 PICSO ® 62 thetreatment 62 paclitaxel eluting 62 LHON 62 antiangiogenic agent 62 assessing T DM1 62 olmesartan 62 Phase IIb clinical trials 62 solithromycin 62 evaluating Prochymal 62 ASPIRE HIGHER 62 EVEREST II 62 Bucindolol 62 AA Amyloidosis 62 Teriflunomide 62 Eluting Coronary Stent System 62 lenalidomide Revlimid R 62 Critical Limb Ischemia CLI 62 systemic immunosuppressive drugs 62 metastatic CRC 62 grade cervical dysplasia 62 neovascular diseases 62 NEUVENGE 62 CentriMag 62 TM Drug Eluting 62 basal bolus regimen 62 atherothrombotic events 62 velafermin 62 essential thrombocythemia ET 62 CVac 62 OvaRex ® MAb 62 peripheral artery 62 OmniWave 62 TLK# 62 ATIR 62 delipidation 62 ductal carcinomas 62 FDG PET imaging 62 LungAlert TM 62 nucleotide analog 62 valve implantation 62 INSPIRE Trial Phase III 62 Embolic Protection System 62 inhaled iloprost 62 drug eluting coronary stent 62 CryoPlasty 62 symptomatic benign prostatic 62 multicenter randomized controlled 62 Arteriovenous 62 Cypher Sirolimus 62 Peripheral Arterial 62 Myocardial Perfusion Imaging 62 Eluting Stent 62 treatment naive genotype 62 interferon ribavirin 62 SPL# Gel vaginal microbicide 62 neointimal 62 OvaRex MAb 62 rhITF 62 Perforomist ™ Inhalation Solution 62 Oral NKTR 62 Exherin TM 62 PRECISE 62 fallopian tube cancers 62 Intravitreal injections 62 myocardial revascularization 62 balloon valvuloplasty 62 Triapine 62 urothelial cancer 62 intensive lipid lowering 62 uricase 62 EnRhythm MRI SureScan pacing 62 transarterial 62 INS# [001] 62 BPS IC 62 xanthine oxidase inhibitor 62 refractory gout 62 elective PCI 62 PROMUS Element Stent 62 dose melphalan 62 leukotriene pathway 62 Carotid artery stenting 62 XL# SAR# 62 post surgical adhesions 62 genomic biomarker 62 Ophena 62 LEUKINE 62 DEEP AF 62 Zalypsis 62 investigational monoclonal antibody 62 lapatinib Tykerb 62 stage IIIb IV 62 lexidronam injection 62 novel histone deacetylase 62 Microwave Ablation System 62 candidates Azedra TM 62 Eculizumab 62 relapsing multiple sclerosis 62 AKT inhibitor 62 artery stenting 62 CRMD# 62 biologic DMARD 62 Pharmacokinetic studies 62 porcine derived 62 DU #b 62 TAXUS Liberté stent 62 lymphoid malignancies 62 macular edema secondary 62 ADVEXIN therapy 62 recombinant tissue plasminogen 62 small molecule activators 62 inhibitor RG# 62 Proxinium TM 62 p# biomarker 62 Tanespimycin 62 randomized controlled multicenter 62 rifalazil 62 adalimumab Humira 62 PEG SN# 62 delivers fluocinolone acetonide FA 62 Endarterectomy 62 CARE HF 62 Cloretazine 62 Pegylated Liposomal Doxorubicin 62 INFUSE ® 62 noninvasive outpatient 62 Temsirolimus 62 alagebrium 62 Polyzene R F 62 ularitide 62 GW# [003] 62 GEM OS1 62 saphenous vein grafts 62 Adhibit 62 Liposomal 62 Initiates Clinical Trial 62 either acutely decompensated 62 Aflibercept 62 chronic thromboembolic pulmonary 62 acute peripheral arterial 62 telomerase inhibitor drug 62 Genasense ® oblimersen 62 HCV RESPOND 2 62 TLIF 62 ChronVac C R 62 recurrent malignant glioma 62 ischemia reperfusion 62 vProtect TM Luminal Shield 62 Aplidin 62 Myelodysplastic Syndrome MDS 62 verteporfin 62 XIENCE V PROMUS Stent 62 steroid refractory 62 Spectranetics laser 62 superficial femoral 62 Percutaneous Tibial Nerve Stimulation 62 hemodialysis patients 62 sipuleucel T 62 rt PA 62 IMPACT DCM 62 NADiA 62 rituximab Rituxan 62 Degarelix 62 oral talactoferrin 62 rALLy clinical trial 62 AFREZZA TM 62 gemcitabine carboplatin 62 selective androgen receptor modulator 62 Demonstrates Sustained 62 Simulect 62 lomitapide 62 bi ventricular pacing 62 ANAVEX #-# [001] 62 FOLOTYN ® 62 melphalan prednisone 62 Cook Zenith TX2 62 myoblast therapy 62 R Saizen R 62 Acute Myocardial Infarction 62 drug zotarolimus 62 Cellvizio R 62 refractory angina 62 SoftScan ® 62 haematologic 62 HuMax HepC 62 NSABP B 62 NSAID induced 62 anti angiogenic agents 62 including eniluracil ADH 62 Tasimelteon 62 SERCA2a 62 R sorafenib tablets 62 E2F Decoy 62 HuMax 62 PSMA ADC 62 HeartNet 62 intimal hyperplasia 62 receptor tyrosine kinase inhibitor 62 histamine dihydrochloride 62 dual endothelin receptor antagonist 62 myocardial infarction ventricular fibrillation 62 Evoltra ® 62 somatostatin analogue 62 Shows Statistically Significant 62 achieved CCyR 62 adjuvant radiotherapy 62 Cardiotoxicity 62 APEX PD 62 Fenretinide 62 #I TM# 62 Chrysalin 61 cardiac resynchronisation therapy 61 Resten MP 61 TAXUS Liberte 61 transthyretin TTR mediated amyloidosis 61 Heterozygous Familial Hypercholesterolemia 61 EGFR HER2 61 severe oral mucositis 61 Initiates Enrollment 61 RE MODEL 61 occlusion CRVO 61 Neovasc Reducer 61 superficial bladder cancer 61 MGN# 61 nicardipine 61 pertuzumab 61 renal denervation 61 glycoprotein IIb IIIa inhibitor 61 complement inhibitor eculizumab 61 urothelial carcinoma 61 TAXUS VI 61 deep venous thromboses 61 Pemetrexed 61 trial evaluating PRX# 61 erythropoietic 61 aerosolized KL4 surfactant 61 randomized multicenter trial 61 ThermoDox ® clinical 61 letrozole Femara 61 GI motility disorders 61 EnteroMedics proprietary neuroblocking technology 61 paclitaxel eluting stent 61 Aortic Aneurysm 61 TO AVOID PREGNANCY WHILE 61 MelaFind R 61 PLX STROKE targeting 61 recurrent glioblastoma 61 ULORIC 61 oral ridaforolimus 61 Intravascular 61 LymphoStat B TM 61 liposomal amphotericin B 61 ProSavin 61 IMiDs ® compound 61 Amrubicin 61 Estrogen Receptor 61 Vitaxin 61 Nonsurgical 61 MiStent DES 61 thoracic aortic aneurysms 61 anti arrhythmic drug 61 mTOR inhibitor 61 introduced NEUGENE 61 VELCADE melphalan 61 transcatheter closure 61 Advanced Microspheres 61 Carotid 61 Hormone Refractory Prostate Cancer 61 STENT 61 hepatitis C viral infection 61 Tyrosine Kinase Inhibitor 61 endovascular therapy 61 BrachySil 61 Anti VEGF 61 bevacizumab Avastin R 61 atherosclerotic renal artery stenosis 61 prokinetic agent 61 humanised monoclonal antibody 61 Alocrest 61 CYPHER R Sirolimus eluting 61 acute coronary syndromes ACS 61 NeuroSTAT ® 61 endoluminal 61 multicenter prospective 61 sunitinib malate 61 r hGH 61 relapsing remitting MS RRMS 61 hemodynamic measurements 61 CardioFit 61 Portal Hypertension 61 haematological cancers 61 duplex ultrasonography 61 eosinophilic asthma 61 RoACTEMRA 61 Kepivance 61 proteasome inhibitor 61 paricalcitol 61 neointimal hyperplasia 61 hypervascular tumors 61 transurethral 61 ER CHOP 61 randomized Phase IIb 61 neovascularisation 61 TAXUS V 61 antithrombotic therapies 61 Prodarsan R 61 resected pancreatic cancer 61 STARFlex 61 postoperative chemotherapy 61 Endoprosthesis 61 atrial arrhythmias 61 systemic fungal infections 61 irinotecan cisplatin 61 cat dander allergy 61 PEAK PlasmaBlade 61 ELACYT 61 EP #R 61 endoluminal stent graft 61 variceal bleeding 61 bifurcation stent 61 Hedgehog Pathway Inhibitor 61 ara C 61 ABSORB 61 prospective multicenter 61 oral rivaroxaban 61 Platinol ® 61 posterolateral fusion 61 prostate carcinoma 61 Vidaza ® 61 PROSTVAC TM 61 IL# PE#QQR 61 DXL# 61 Ceplene/IL-2 61 metastatic RCC 61 randomized discontinuation 61 oral antiplatelet therapy 61 heparin induced thrombocytopenia 61 acute GvHD 61 Epidermal Growth Factor Receptor 61 recurrent pulmonary embolism 61 Romiplostim 61 PRT# 61 Orthokine 61 Xenograft 61 patients undergoing percutaneous 61 Refractory Angina 61 Stenting Trial CREST 61 ACAPODENE 61 endovascular stent graft 61 percutaneous interventions 61 Plicator 61 MEND CABG 61 Demonstrates Positive 61 Echocardiographic 61 pelvic malignancies 61 RLY# 61 peptide conjugated 61 VerifyNow P#Y# 61 embolic protection device 61 forodesine 61 saphenous vein graft 61 TransVax ™ 61 CCX# 61 esophageal candidiasis 61 Sorafenib Nexavar 61 placebo controlled clinical 61 dasatinib Sprycel 61 Thal Dex 61 radiation sensitizer 61 sacral nerve stimulation 61 Sipuleucel T 61 SCH # 61 p# inhibitor 61 treat chronic sinusitis 61 CMV reactivation 61 Cand5 61 TNFerade TM 61 TAXUS Liberte Stent 61 Ranibizumab 61 MIST II 61 resorbable biomaterials 61 denileukin diftitox 61 parathyroid carcinoma 61 oral Hycamtin 61 Dasatinib 61 CINtec R 61 Pivotal Clinical Trial 61 percutaneous transluminal coronary angioplasty 61 Clinical Outcome 61 Combivir Kivexa 61 NOD SCID mice 61 PERSEUS 61 5 Fluorouracil 61 allogeneic hematopoietic stem cell 61 candidate CRLX# 61 Certolizumab pegol 61 Diabetic Macular Edema 61 paclitaxel Taxol 61 receptor antagonism 61 tumor necrosis 61 angiographically 61 TASKi2 61 rosuvastatin #mg 61 Castration Resistant Prostate Cancer 61 diabetic retinopathy DR 61 Erimos 61 Archexin 61 Tß4 61 Antitumor Activity 61 P#X# antagonist 61 PROMUS R 61 Elagolix 61 Solazed TM 61 Vicinium TM 61 Epigenomics proprietary 61 rALLy 61 pharmacokinetic PK 61 Percutaneous Coronary Intervention 61 MYCAMINE 61 polycythemia vera essential thrombocythemia 61 interstitial cystitis IC 61 MIVI III 61 azilsartan medoxomil 61 Bionate ® PCU 61 choroidal vasculopathy 61 INVANZ 61 endothelin antagonist 61 Soliris eculizumab 61 basiliximab 61 cediranib 61 Meets Primary Endpoint 61 phase IIa clinical 61 Percutaneous vertebroplasty 61 anti infective treatments 61 viral kinetics 61 intraoperative radiotherapy 61 Generx TM 61 VAPRISOL 61 Glufosfamide 61 intravenous cyclophosphamide 61 accumulate preferentially 61 Perceiva 61 Oxiplex 61 histologically proven 61 bortezomib Velcade 61 keloid scarring 61 thorough QT 61 TYSABRI natalizumab 61 ASTEROID 61 DAPT 61 immunodeficiency disorders 61 CIMZIA TM 61 Adnectin 61 TMS Therapy 61 Lisofylline 61 STARFlex ® 61 Phase IIa trials 61 mild hepatic impairment 61 EVIZON TM 61 DASISION 61 thymosin beta 4 61 ® bortezomib 61 Onalta TM 61 Augment Injectable 61 davunetide intranasal AL 61 interferon alpha IFN 61 ID NCT# 61 APTIVUS R 61 Fludarabine 61 postoperative AF 61 BioMatrix TM 61 ADVANCE PD 61 palifermin 61 ROTARIX 61 Atrasentan 61 ribavirin Copegus ® 61 PEGylated interferon beta 1a 61 intracranial hemorrhage ICH 61 antiangiogenic therapy 61 TAXUS TM 61 certolizumab 61 unfractionated heparin UFH 61 metastatic gastric 61 novel emulsion formulation 61 Completes Patient Enrollment 61 resectable pancreatic cancer 61 Benign Prostatic Hyperplasia BPH 61 alfuzosin 61 sargramostim 61 portal vein thrombosis 61 Enzastaurin 61 THR beta agonist 61 CaPSURE 61 Edwards SAPIEN valve 61 Infarct 61 hemostatic efficacy 61 INCB# [003] 61 trastuzumab Herceptin ® 61 RSD# oral 61 hyperoxaluria 61 Study Evaluating 61 stem cell engraftment 61 vinca alkaloid 61 dextofisopam 61 Safinamide 61 BRIM3 61 Oral Fingolimod 61 bardoxolone methyl 61 ALK inhibitors 61 carotid stents 61 pharmacokinetic equivalence 61 Drug eluting stent 61 acute humoral rejection 61 BCIRG 61 NMIBC 61 Intra arterial 61 Severe Sepsis 61 FS Antihemophilic Factor Recombinant 61 primary patency 61 Electronic Brachytherapy System 61 dermaPACE TM 61 Ischemic 61 histone deacetylase HDAC 61 humanized monoclonal 61 multiple myeloma MM 61 LAB CGRP 61 CANCIDAS 61 BioSTAR R 61 Phase III multicenter 61 Artelon ® 61 Recurrent Glioblastoma 61 pediatric malignancies 61 vitro pharmacology 61 transthoracic 61 carotid stent 61 coronary intervention 61 Reports Preclinical Data 61 metastatic renal cell carcinoma 61 Radical prostatectomy 61 BHT DNA 61 Zevalin consolidation 61 CERVARIX 61 RE LY 61 Coronary CTA 61 rFVIIa 61 Septin9 biomarker 61 protein kinase inhibitors 61 adenoma recurrence 61 pretransplant 61 Trofex 61 ENMD # 61 electrophysiologic 61 chemoradiation therapy 61 pharmacodynamic properties 61 cerebral vasospasm 61 choroidal neovascularization 61 intravesical instillation 61 Novolimus 61 intradermal injections 61 Valdoxan 61 CINTREDEKIN BESUDOTOX 61 Regenerative Cells 61 beta estradiol 61 antiangiogenic agents 61 Acute Coronary Syndromes ACS 61 PORxin TM platforms 61 Denufosol 61 aortic root replacement 61 patented Bioral 61 number NCT# ClinicalTrials.gov 61 Advanced Melanoma 61 EECP R 61 chronic idiopathic thrombocytopenic purpura 61 Coronary artery bypass grafting 61 hoFH 61 prospectively randomized 61 NEVO TM 60 pan HDAC inhibitor 60 Xcytrin R 60 drug eluting stent DES 60 drug eluting coronary stents 60 NAGS deficiency 60 GORE TAG ® 60 Zysolin TM 60 lipoprotein lipase deficiency LPLD 60 Cypher Stent 60 Natalizumab 60 Tacrolimus 60 EndoTAG TM 60 Activity Assay 60 Phase IIIb study 60 Liprostin 60 neuroprotectant 60 CD# monoclonal antibody 60 rhIGF-I/rhIGFBP-3 60 Lumbar Interbody Fusion 60 gynecologic procedures 60 mediated inhibition 60 Cotavance 60 Zyclara 60 Unstable Angina 60 deCODE AF TM 60 Aplidin R 60 CaPre TM 60 Cleviprex TM clevidipine 60 PROMUS TM 60 corneal inlay 60 percutaneous intervention 60 external counterpulsation systems 60 hypereosinophilic syndrome 60 Mipomersen 60 Transcranial Magnetic Stimulation TMS 60 HGS ETR1 mapatumumab 60 Canvaxin TM 60 myocardial necrosis 60 fusion enhancers 60 refractory metastatic 60 Aurora Kinase 60 intracranial stenosis 60 V Everolimus Eluting Coronary 60 NeuroStar TMS Therapy 60 null responder 60 antifibrotic 60 refractory chronic lymphocytic 60 Gliadel Wafer 60 Zenvia ™ 60 targeting miR 60 Pelvic Organ Prolapse 60 pharmacodynamic profile 60 Allogeneic 60 Capesaris 60 sitaxsentan 60 FOLFOX4 60 rebleeding 60 ximelagatran 60 Ecallantide 60 Antiviral Activity 60 Parathyroid Hormone 60 prospective multicenter randomized 60 transthyretin amyloidosis 60 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 60 multicenter randomized placebo controlled 60 paroxysmal nocturnal hemoglobinuria 60 GeneICE 60 sirolimus eluting stent 60 Central Retinal Vein 60 lumbar spinal stenosis LSS 60 oral prodrug 60 liposome formulation